EUROFINS SCIENT (OTCMKTS:ERFSF) Shares Gap Down - What's Next?

Key Points

• Eurofins Scientific's stock price gapped down from $79.13 to $76.15 before market opening, reflecting a decrease of 1.1%.
• HSBC Global Research downgraded Eurofins Scientific from a "strong-buy" rating to a "hold" rating, while Citigroup maintained a "neutral" rating.
• The company has a debt-to-equity ratio of 0.77, indicating a healthy balance of debt in relation to its equity.

EUROFINS SCIENT (OTCMKTS:ERFSF - Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $79.13, but opened at $76.15. EUROFINS SCIENT shares last traded at $76.15, with a volume of 80 shares.

Wall Street Analysts Forecast Growth

ERFSF has been the topic of several research analyst reports. Hsbc Global Res cut EUROFINS SCIENT from a "strong-buy" rating to a "hold" rating in a research report on Friday, April 25th. Citigroup restated a "neutral" rating on shares of EUROFINS SCIENT in a research note on Friday, July 25th. Finally, HSBC lowered EUROFINS SCIENT to a "hold" rating in a research note on Friday, April 25th. Five research analysts have rated the stock with a hold rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold".

EUROFINS SCIENT Price Performance

The firm's 50-day moving average is $73.38 and its two-hundred day moving average is $63.03. The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77.

About EUROFINS SCIENT

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.